Terbinafine Hydrochloride Patent Expiration

Terbinafine Hydrochloride was first introduced by Novartis Pharmaceuticals Corp in its drug Lamisil on Dec 30, 1992. Another drug containing Terbinafine Hydrochloride is Lamisil At. 18 different companies have introduced drugs containing Terbinafine Hydrochloride.


Terbinafine Hydrochloride Patents

Given below is the list of patents protecting Terbinafine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lamisil At US5681849

(Pediatric)

Pharmaceutical composition for topical applications Apr 28, 2015

(Expired)

Karo Hlthcare
Lamisil At US5681849 Pharmaceutical composition for topical applications Oct 28, 2014

(Expired)

Karo Hlthcare



Terbinafine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Terbinafine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Terbinafine Hydrochloride. The first generic version for Terbinafine Hydrochloride was by Aurobindo Pharma Ltd and was approved on Jul 2, 2007. And the latest generic version is by Breckenridge Pharmaceutical Inc and was approved on Jun 4, 2010.

Given below is the list of companies who have filed for Terbinafine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.